Reunion Neuroscience Inc (REUN.CA) Stock News

Canada - TSX:REUN - CA76134G1037 - Common Stock

1.42 CAD

-0.04 (-2.74%)

Last: 8/2/2023, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

REUN.CA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. to Participate in October Investor Conferences

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate a Phase 2 Study of RE104 for the Treatment of Postpartum Depression

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement

2 years ago - By: Seeking Alpha

Reunion Neuroscience shareholders approve acquisition by MPM BioImpact (TSX:REUN:CA)

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference

2 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Provides 2023 Corporate Update

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Puts in Place At-The-Market Equity Facility

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial Results

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience to Present at Upcoming November Conferences

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience CEO to Participate on Panel at 2022 Horizons Perspectives on Psychedelics Conference

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces Executive Changes

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

3 years ago - By: Reunion Neuroscience Inc. - Mentions: REUN

Reunion Neuroscience Inc. Announces 2022 Annual General Meeting of Shareholders

3 years ago - By: Reunion Neuroscience Inc. - Mentions: FTRP FTRP.CA FTRP-WT.CA

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022